# Vincent Cheung

> Vincent Cheung is a convertible note investor at Pivotal bioVenture Partners backing Biopharma. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Pivotal bioVenture Partners](https://shizune.co/investors/profile/pivotal-bioventure-partners)
- Location: Hong Kong, Hong Kong
- Total investments: 1
- Last investment: Jun 2018
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/vincent-cheung-15423120

Vincent Cheung is a convertible note investor at Pivotal bioVenture Partners in Hong Kong focused on Biopharma and Therapeutics. Vincent Cheung serves as a Founder & Managing Partner at Pivotal bio venture Partners.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Stealth BioTherapeutics | Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function. | $100M | Convertible Note | Jun 18, 2018 |  |

1 of 1 investments shown.

## Co-investors
- [Atlantis Investment Management](https://shizune.co/investors/profile/atlantis-investment-management) — VC Fund, 1 deal together
- [BVCF](https://shizune.co/investors/profile/bioveda-china-fund) — VC Fund, 1 deal together
- [CMBC Capital Holdings](https://shizune.co/investors/profile/cmbc-capital-holdings) — VC Fund, 1 deal together
- [Kingdon Capital](https://shizune.co/investors/profile/kingdon-capital) — VC Fund, 1 deal together
- [Ocean Equity Partners](https://shizune.co/investors/profile/ocean-equity-partners) — VC Fund, 1 deal together
- [Sagamore Investments](https://shizune.co/investors/profile/sagamore-investments) — VC Fund, 1 deal together

## About Pivotal bioVenture Partners

VC Fund · San Francisco, United States

Pivotal bioVenture Partners is a $300 million life sciences venture capital fund established in 2017. They invest in privately held North American and European companies focused on innovative therapeutic products and platforms to address major unmet medical needs. They invest at all stages in a company’s evolution, from company creation through midand late stage clinical development. Their team brings diverse experience in venture capital, company building, and drug discovery and development to the table in working with entrepreneurs to advance their businesses.

5 contacts available at Pivotal bioVenture Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Ash Khanna | Partner, Board Member HotSpot Tx, Bolt Bio, Fountain Tx and Evommune | https://shizune.co/investors/profile/ash-khanna |
| Heather Preston | Managing Partner | https://shizune.co/investors/profile/heather-preston |
| Jeni Lee | Partner | https://shizune.co/investors/profile/jeni-lee-ba22 |
| Robert Hopfner | Managing Partner | https://shizune.co/investors/profile/rob-hopfner |
| Vincent Cheung | Managing Partner | https://shizune.co/investors/profile/vincent-cheung-2 |

## Similar investors

### Similar stage
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund

## FAQ

### What does Vincent Cheung invest in?

Vincent Cheung invests primarily in Biopharma, Therapeutics and Biotechnology startups, most often at Convertible Note stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Vincent Cheung last invest?

The most recent investment recorded for Vincent Cheung closed in Jun 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
